Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'
Go back to Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'| (NASDAQ: URGN) | Delayed: 27.60 +1.00 (3.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.60 | 52 Week High | $ | |||
| Open | $26.73 | 52 Week Low | $ | |||
| Day High | $28.10 | P/E | N/A | |||
| Day Low | $26.67 | EPS | $ | |||
| Volume | 329,754 | |||||
